Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Environmental Topics
  • Laws & Regulations
  • Report a Violation
  • About EPA
Risk Assessment
Contact Us

The EPA Adverse Outcome Pathway Database (Aop-Db) Application User Manual

On this page:

  • Overview
  • Downloads
The manual covers basic search functionality and description of the content and format of the data accessible through the AOP-DB. Adverse outcome pathways (AOPs) are a conceptual framework intended to enhance the utility of pathway-based data for use in risk-based regulatory decision support. The framework is designed to aid the organization and evaluation of predictive relationships between measures of the initiation or progression of a stressor-induced perturbation and adverse outcomes that occur at a level of biological organization considered relevant to regulatory decision-making.

The Agency has committed to research that advances predictive applications of the AOP framework under the CSS Research Program. The research provides a critical scientific foundation for 21st century approaches to toxicity testing which seek to make increased use of lower cost, higher throughput and/or higher content, in vitro, in silico, and/or short-term in vivo testing for single chemical hazard assessment. It also provides the scientific framework to assess the human/ecological relevance of pathway-based effects across different model systems and address the challenges posed by exposure to multiple stressors in the environment.

Central to this effort is the development of an AOP database (AOP-DB) to house, organize, profile and disseminate the AOP information. Potential users of the AOP-DB are any researchers (e.g. International or National, government, academic, and industry) interested in the study of AOPs, such as federal and program partners, OECD (Organization for Economic Co-operation and Development) partners, or AOPWiki users that may like organized biological information on specific AOPs for basic research or regulatory purposes.

Impact/Purpose

This user manual is used for training and guidance in the use of the EPA Adverse Outcome Pathway Database (AOP-DB).

Citation

U.S. EPA. The EPA Adverse Outcome Pathway Database (Aop-Db) Application User Manual. U.S. EPA Office of Research and Development, Washington, DC, EPA/600/R-21/136, 2021.

Download(s)

This document has been reviewed in accordance with U.S. Environmental Protection Agency policy and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use.

  • The EPA Adverse Outcome Pathway Database (AOP-DB) Application User Manual (PDF)  (17  pp, 952.1 KB, about PDF)
  • AOP-Database

Related Link(s)

  • Mortensen, H.M., et al. The 2021 update of the EPA's adverse outcome pathway database. Sci Data 2021;8(1):169.
  • Risk Assessment Home
  • About Risk Assessment
  • Risk Recent Additions
  • Human Health Risk Assessment
  • Ecological Risk Assessment
  • Risk Advanced Search
    • Risk Publications
  • Risk Assessment Guidance
  • Risk Tools and Databases
  • Superfund Risk Assessment
  • Where you live
Contact Us to ask a question, provide feedback, or report a problem.
Last updated on November 16, 2021
United States Environmental Protection Agency

Discover.

  • Accessibility Statement
  • Budget & Performance
  • Contracting
  • EPA www Web Snapshots
  • Grants
  • No FEAR Act Data
  • Privacy
  • Privacy and Security Notice

Connect.

  • Data
  • Inspector General
  • Jobs
  • Newsroom
  • Open Government
  • Regulations.gov
  • Subscribe
  • USA.gov
  • White House

Ask.

  • Contact EPA
  • EPA Disclaimers
  • Hotlines
  • FOIA Requests
  • Frequent Questions

Follow.